dfp_header_hidden_string

Get our free email newsletter with just one click

Writing award set up to honour playwright Kevin Elyot

Kevin Elyot Kevin Elyot
by -

A new writing award is to be set up in the name of actor and playwright Kevin Elyot, who died in 2014.

The writer, whose plays include My Night With Reg and Mouth to Mouth, is the inspiration for a new Bristol-based scheme launched to nurture promising playwrights.

The Kevin Elyot Award will enable one playwright to become a resident at the University of Bristol’s theatre collection, which houses Elyot’s archive. The winning writer will receive £3,000 to fund a four-week residency, during which they will be supported to begin creating a new work inspired by the archive.

The award will run annually during the summer, and has been funded by an endowment given to the university – where Elyot studied – by his family.

Jo Elsworth, director of the theatre collection, said she hoped the award would enable a new generation of writers to find creative inspiration from Elyot’s work, “so that the spirit of Kevin’s life and work will live on”.

“On a more personal level, we also hope that this award will make a tangible difference to the award winner and help them develop their own career in writing,” she added.

The award will be judged by a panel including actor Lindsay Duncan and playwright Catherine Johnson, alongside members of the university’s theatre department.

We need your help…

When you subscribe to The Stage, you’re investing in our journalism. And our journalism is invested in supporting theatre and the performing arts.

The Stage is a family business, operated by the same family since we were founded in 1880. We do not receive government funding. We are not owned by a large corporation. Our editorial is not dictated by ticket sales.

We are fully independent, but this means we rely on revenue from readers to survive.

Help us continue to report on great work across the UK, champion new talent and keep up our investigative journalism that holds the powerful to account. Your subscription helps ensure our journalism can continue.

loading...
^